Purchase Order 75N93024P00194
Award Date 1/1/24
Potential Completion Date 11/25/24
Potential Value $44K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $32,634.00 firm fixed-price purchase order to Qiagen, LLC, a division of the international life sciences company Qiagen N.V. The contract is for the provision of the Human Gene Mutation Database (HGMD) data download. Qiagen has provided various products and services to support federal agencies' biomedical research, public health, and healthcare programs...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $43,587.50 firm fixed price purchase order to Qiagen, LLC. Qiagen will perform under the contract from its place of performance in Germantown, Maryland between December 20, 2023 and November 25, 2024. The description indicates Qiagen will provide products or services under contract number AMBIS #2196972 in support of NIH/NIAID programs, though specifics of the...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $33,646.00 firm-fixed-price purchase order to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for a 1-year license to access the Human Gene Mutation Database, which provides data on approximately 200,000 human genomic mutations. This data supports NIAID's efforts to build a custom bioinformatics...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, awarded a $4,094.11 firm-fixed-price purchase order to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. This award does not have a set-aside designation. The award supports Qiagen's provision of products and services to NIAID, such as DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, and bioinformatics...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $66,514.95 firm fixed-price purchase order to Qiagen, LLC for clinical long read genomics services supporting the NIAID Centralized Sequencing Program, Human Genome Mutation Database (HGMD) initiative. The contract, effective from March 1, 2026 through February 28, 2027, will be performed at Qiagen's facility in Germantown, Maryland. This award was made without a small business set-aside designation, reflecting the...
- Qiagen, LLC has been awarded a firm fixed price purchase order totaling $18,780.30 by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases. The contract is for an annual service agreement to provide support for Qiagen's QIAcuity Eight Digital PCR System in Bethesda, Maryland through February 27, 2025. No set-aside designation was used for this award to support the agency's research into allergies and infectious...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $54,093.80 contract is for the provision of unspecified products and services, as there is no set-aside designation and no further description of the requirements. Qiagen is a long-standing federal contractor that has provided...
- The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a firm-fixed price purchase order contract to Qiagen, LLC, a division of Qiagen N.V., for $32,634.00. The contract provides one-year access to the Human Gene Mutation Database for clinical use at the NIH Clinical Center to support a custom bioinformatics pipeline for analyzing genomic data from patients enrolled in NIAID clinical protocols. This sole-source...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $17,044.72 firm fixed-price purchase order to Qiagen, LLC, a division of the international provider Qiagen N.V. The order is for 2 kits of HOTSTARTAQ DNA POLYMERASE (25000). There is no set-aside designation noted. Qiagen has provided a range of products and services to various federal agencies, including DNA/RNA extraction kits, next-generation sequencing,...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $126,095.20 firm fixed price purchase order to Agilent Technologies Inc. Customer Service And Sales Division. Under the terms of the contract, Agilent will provide 17 single lot-matched fluorescent DNA probe labeling kits, 100 lot-matched cDNA expression microarrays, gene expression hybridization and wash pack kits, and shipping and handling services in...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $43,587.50 firm fixed price purchase order to Qiagen, LLC for one catalog item #834083, HGMD Data Download for clinical use by a medium-sized enterprise. The place of performance will be Qiagen's Germantown, Maryland division. The period of performance is January 1, 2024 through November 25, 2024. No set aside designation or subcontractors were indicated. The National Institute of Allergy and Infectious Diseases supports research on infectious, immunologic and allergic diseases, so this purchase is likely to support genomic or clinical research efforts.
Generated 12/28/23, 9:12 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $43.6k | 12/27/23 |